↓ Skip to main content

Dove Medical Press

Denosumab: a new option in the treatment of bone metastases from urological cancers

Overview of attention for article published in OncoTargets and therapy, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
46 Mendeley
Title
Denosumab: a new option in the treatment of bone metastases from urological cancers
Published in
OncoTargets and therapy, September 2012
DOI 10.2147/ott.s30578
Pubmed ID
Authors

Takeshi Yuasa, Shinya Yamamoto, Shinji Urakami, Iwao Fukui, Junji Yonese

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 2%
Egypt 1 2%
Unknown 44 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 17%
Other 7 15%
Student > Ph. D. Student 7 15%
Student > Doctoral Student 5 11%
Student > Bachelor 4 9%
Other 7 15%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 17 37%
Agricultural and Biological Sciences 9 20%
Biochemistry, Genetics and Molecular Biology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Chemistry 2 4%
Other 2 4%
Unknown 9 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2021.
All research outputs
#5,557,364
of 25,759,158 outputs
Outputs from OncoTargets and therapy
#281
of 3,014 outputs
Outputs of similar age
#39,284
of 188,922 outputs
Outputs of similar age from OncoTargets and therapy
#2
of 13 outputs
Altmetric has tracked 25,759,158 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,014 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,922 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.